Evidence map›Paper›PMID 42325234›Full record

ArticleJournal of microscopy and ultrastructure

The Possible Ameliorative Effect of Naringenin versus Flaxseed Oil on Renal Lead Toxicity in Male Albino Rats: A Histological and Immunohistochemical Study.

Rania Hamdy Elsyade, Doaa Ramadan Sadek

Abstract read
In one paragraph

Article in Journal of microscopy and ultrastructure. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Rania Hamdy ElsyadeDepartment of Anatomy and Embryology Faculty of Medicine, Helwan University, Cairo, Egypt.
Doaa Ramadan SadekDepartment of Histology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Lead is an abundant and nonbiodegradable pollutant that is present in nature. The renal toxicity of lead is not only a functional disturbance but also a structural damage. Naringenin is a natural flavonoid that has anti-inflammatory, anti-apoptotic, and anticancer effects. Flaxseed oil (FO) is the richest dietary plant source of omega-3 polyunsaturated fatty acids and has beneficial effects on dyslipidemia and cardiovascular diseases. Objective: To investigating the possible ameliorative histological and immunohistochemical effects of naringenin versus FO on renal lead toxicity in male albino rats. Materials and Methods: Thirty-two rats were allocated to four groups: Group I, control; Group II, lead acetate (30 mg/kg/day); Group III, lead acetate and naringenin (20 mg/kg/day), and Group IV, lead acetate and FO (2 g/kg/day). All chemicals were given orally as a single daily dose by oral gavage for 30 days. Sections of kidney tissues were examined using H and E, Masson's trichrome stain, periodic acid-Schiff stain, and immunohistochemical staining (BCL-2-associated X protein [BAX] and inducible nitric oxide synthase [iNOS]). Results: Lead caused an increase in serum urea and creatinine. A histological study revealed the atrophy of some glomerular capillaries, while other capillaries showed hypertrophic changes. Tubular degenerative changes with deposition of hemosiderin pigments were confirmed by an increase in BAX and iNOS immunoexpression. Naringenin and FO ameliorated the functional and structural alterations caused by lead intoxication. Conclusion: Both naringenin and FO through their anti-oxidative stress action can improve structural and functional alterations in the rat kidneys which are caused by lead intoxication. However, the action of naringenin was superior to FO.

Indexed as

BCL-2-associated X proteinflaxseed oilinducible nitric oxide synthasekidneylead acetatenaringenin

Identifiers

PMID42325234
PMCPMC13278255

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.